RA Treatment Strategies

Clifton Bingham, M.D. - Jon Giles, M.D.

Abstract 657: Evidence for a Window Of Opportunity in a Double-Blind Randomized Clinical Trial in Patients with Undifferentiated Arthritis: The Probable Rheumatoid Arthritis: Methotrexate Versus Placebo Treatment (the Prompt)-Study

658. Remission Induction in Early Rheumatoid Arthritis (RA) with Initial Infliximab (IFX) and Methotrexate (MTX) Therapy: The Disease Course After IFX Discontinuation in The BeSt Trial

Abstract 1306: Induction of Remission in Patients with Early Rheumatoid Arthritis (RA) Initially Treated with Either Prednisone or Infliximab Combination Therapy

Abstract 1308: A Randomised Controlled Trial of Step Up Therapy Versus Triple Therapy In Early Active Rheumatoid Arthritis - The TEAR Study

Abstract 1309: Does Addition of Infliximab to Triple DMARD Plus Prednisolone Therapy Increase Rate of Remissions in Patients with Early Active Rheumatoid Arthritis? A Randomized Double-Blind Placebo-Controlled Study

L43. The Efficacy and Safety of Abatacept or Infliximab in RA Patients with an Inadequate response to MTX: Results from a 1-year Double-blind, Randomized, Placebo-controlled Trial

• Rheumatoid Arthritis
• Treatment Strategies
• TNF Antagonists
• B-Cell Depletion
• Other Agents
• OA Clinical Aspects
• Juvenile RA / Pediatric Rheumatology
• Systemic Lupus Erythematosus
• Vasculitis
• Scleroderma
• Fibromyalgia
• Spondyloarthropathies
• Myositis
• Pregnancy in AutoImmune Disease
• Non-Pharmacologic Management
• Basic Science
• Epidemiology
• Psychosocial